A PROSPECTIVE EVALUATION OF LYMPHOMYOSOT IN THE MAINTENANCE TREATMENT OF BREAST CANCERRELATED LYMPHEDEMA

14

western union transfer fee FORNER-CORDERO I. 1, NAVARRO-MONSOLIU R. 1, MUÑOZ-LANGA J. 2

1 Lymphedema Unit, Rehabilitation Department, Hospital Universitario La Fe, Valencia, Spain

2 Clinical Oncology Unit, Hospital Universitario Dr. Peset, Valencia, Spain

Corresponding author: Isabel Forner-Cordero, MD

Andres Mancebo 3 6, 12

46023 – Valencia (Spain)

Phone: 34-649 17 98 52

E-mail: iforner@saludalia.com

ABSTRACT

Purpose: To assess the efficacy and tolerability of the combination

of Lymphomyosot with compression hosiery in the maintenance

treatment of breast cancer-related lymphedema.

Methods: Female patients diagnosed with breast cancer, who had

undergone unilateral breast surgery and exhibited stage II-IV arm

lymphedema secondary to treatment received oral Lymphomyosot

and were monitored over a period of 6 months. Primary outcome

measure was the percentage reduction in lymphedema volume.

Results: Thirty-six patients, with a mean age of 60 years and a

long (4 years) disease duration were included. The reduction of

lymphedema volume was 29.5% (95% CI, 15.0 to 43.9) at month

1, 31.5% (95% CI, 13.2 to 49.9) at month 3, and 41.2% (95% CI,

17.6 to 64.9) at month 6. Lymphomyosot was well-tolerated.

Conclusions: Lymphomyosot combined with compression hosiery

might be an efficacious and well-tolerated therapeutic alternative

for the maintenance treatment of patients with breast cancerrelated

lymphedema.

KEY WORDS: Breast cancer, lymphedema, compression hosiery,

compression therapy, Lymphomyosot